Eagles quarterback Jalen Hurts is expected to miss the rest of the 2026 season after doctors found blood clots in both of his lungs.
Zoom in: Specialists in London first diagnosed a left calf superficial vein thrombosis. After further testing and monitoring, the diagnosis became a deep vein thrombosis plus bilateral pulmonary emboli, the Eagles and Hurts's agent Nicole Lynn said in a statement.
- "His treatment should only involve anticoagulation (i.e. 'blood thinners')," the statement said, describing Hurts as "clinically stable" with "no significant functional limitations" and a prognosis for full recovery that is "very good".
The backstory: The Eagles found a clot in Hurts's leg before their Week 5 game in London and determined he could play. A follow-up ultrasound back in Philadelphia showed the clot had moved, which prompted the team to rule him out against the Panthers.
By the numbers: Treatment runs about three months, and contact football waits until he is off the anticoagulants. Philadelphia sits at 2-4, second in the NFC East despite the losing record.
- Tanner McKee, 26, started Week 6 against Carolina and struggled to move the offense.
Yes, but: The team anticipates no long-term effects, and the statement says Hurts should get the chance to resume contact activities once he stops the medication.
Why it matters: A pulmonary embolism is a medical emergency, and this one surfaced in an elite athlete who had already been cleared to play. The sequence that doctors watch for is exactly the one here: long-haul travel, then a calf clot a specialist first read as superficial, then clots that traveled to the lungs.
